Théodora Mahoukèdè Zohoncon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Théodora Mahoukèdè Zohoncon has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Jacques Simpore
Département de Biochimie Microbiologie, Université Joseph Ki-Zerbo (UFR/SVT-UJKZ) ; 03 BP 7021 Ouagadougou, Burkina Faso.
12 shared publications - Abdoul Karim Ouattara
Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph Ki‐Zerbo Ouagadougou Burkina Faso
7 shared publications - Florencia Wendkuuni Djigma
Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph Ki‐Zerbo Ouagadougou Burkina Faso
6 shared publications - Abdou Azaque Zouré
Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE) Université Joseph Ki‐Zerbo Ouagadougou Burkina Faso
4 shared publications - Albert Théophane Yonli
Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), 03 BP 7021 Ouagadougou 03, Burkina Faso.
4 shared publications - Dorcas Obiri-Yeboah
Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana
4 shared publications
Latest Publications
- 14 May 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Molecular characterization of IMP and NDM resistance genes in carbapenemase-producing Enterobacteriaceae isolates in urine
Extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae, implicated in urinary tract infections, represent a major challenge and limit therapeutic options. Our study sought to characterize the genes of resistance to IMP and NDM in urine samples from patients in the city of Ouagadougou by real-time PCR. This cross-sectional study focused on 130 bacterial isolates collected from February to July 2023 at HOSCO and CERBA. The determination of the enterobacterium species was followed by the performance of an antibiogram. Gene detection consisted of the extraction of bacterial DNA and its amplification by real-time PCR. 60 isolates came from male patients (46.2%) and 70 from female patients (53.8%), for a sex ratio (M/F) of 0.85 and an age between 51 days and 83 years, including 87.7% over 20 years. The most frequent species were respectively Escherichia coli (64.6%), Klebsiella sp. (30.8%), Proteus sp. (3.1%) and Enterobacter cloacae (1.5%). Resistance to imipenem for all Enterobacteriaceae strains was 19.2% and the majority gene was NDM (70%). The IMP gene was rare with only one positive case (0.8%) which was a coexistence of the 2 genes IMP and NDM. The NDM gene could be a cause of resistance to antibiotics, particularly imipenem, and special attention should be paid to Escherichia coli in the fight against the emergence of extended-spectrum β-lactamases. Real-time PCR could serve as a routine analytical technique to facilitate obtaining more reliable results in a short timeframe.
- 14 May 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Molecular characterization of IMP and NDM resistance genes in carbapenemase-producing Enterobacteriaceae isolates in urine
Extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae, implicated in urinary tract infections, represent a major challenge and limit therapeutic options. Our study sought to characterize the genes of resistance to IMP and NDM in urine samples from patients in the city of Ouagadougou by real-time PCR. This cross-sectional study focused on 130 bacterial isolates collected from February to July 2023 at HOSCO and CERBA. The determination of the enterobacterium species was followed by the performance of an antibiogram. Gene detection consisted of the extraction of bacterial DNA and its amplification by real-time PCR. 60 isolates came from male patients (46.2%) and 70 from female patients (53.8%), for a sex ratio (M/F) of 0.85 and an age between 51 days and 83 years, including 87.7% over 20 years. The most frequent species were respectively Escherichia coli (64.6%), Klebsiella sp. (30.8%), Proteus sp. (3.1%) and Enterobacter cloacae (1.5%). Resistance to imipenem for all Enterobacteriaceae strains was 19.2% and the majority gene was NDM (70%). The IMP gene was rare with only one positive case (0.8%) which was a coexistence of the 2 genes IMP and NDM. The NDM gene could be a cause of resistance to antibiotics, particularly imipenem, and special attention should be paid to Escherichia coli in the fight against the emergence of extended-spectrum β-lactamases. Real-time PCR could serve as a routine analytical technique to facilitate obtaining more reliable results in a short timeframe.
- 28 February 2026
- Vol. 72 (2) , 30-43
Glutathione S-Transferase Mu1 polymorphisms and environmental factors in cervical cancer susceptibility: a systematic review and meta-analysis.
Cervical cancer is a multifactorial disease like any other human cancer. Among these factors, genetic polymorphisms of Glutathione S-Transferase Mu1 (GSTM1) have been incriminated, but the studies results remain controversial. The objective of this meta-analysis was to study the influence of GSTM1 polymorphisms on the occurrence of cervical cancer and to explore interactions between genes and human papillomavirus (HPV) infection and exposure to tobacco smoke. A meta-analysis was conducted on studies published up to June 12, 2025, from six databases: ScienceDirect, Embase, Scopus, PubMed, Google Scholar, Web of Science. Eligible studies included all case-control investigations that assessed the association between GSTM1 polymorphisms and the risk of cervical cancer. Odds ratios and confidence intervals from the studies were used to estimate the combined effect size. Statistical analyses were conducted using both the DerSimonian and Laird random-effects model and Mantel and Haenszel fixed-effect model with a 95% confidence interval. Subgroup analyses were performed to identify potential sources of variability. A significant association was observed between the GSTM1-null and an increased risk of Cervical Cancer (ORCC=1.47, Pz=0.011) and Squamous Intraepithelial Lesions (ORSIL=1.42, Pz=0.035) compared with the GSTM1-present. The included studies showed high heterogeneity. Overall, carriers of the GSTM1-null had a higher likelihood of developing Cervical Cancer compared to carriers of the GSTM1-present. In subgroup analyses, an increased risk associated with the GSTM1-null was found among Asian populations (ORCC=1.54, Pz=0.002) and according to sample type, in blood DNA extracts (ORCC=1.27, Pz=0.052). Furthermore, the GSTM1-null was associated with increased risk in HPV+ women (ORCC=4.88, Pz=0.005) and in women exposed to tobacco smoke (ORCC=1.35, Pz=0.033). According to histological type, GSTM1-null was also associated with the development of Squamous Cell Carcinoma (ORSCC=1.52, Pz=0.020). in conclusion, GSTM1-nullwere associated with an increased risk of cervical cancer in women, especially in HPV+ women and those exposed to tobacco smoke.
- 28 February 2026
- Vol. 72 (2) , 30-43
Glutathione S-Transferase Mu1 polymorphisms and environmental factors in cervical cancer susceptibility: a systematic review and meta-analysis.
Cervical cancer is a multifactorial disease like any other human cancer. Among these factors, genetic polymorphisms of Glutathione S-Transferase Mu1 (GSTM1) have been incriminated, but the studies results remain controversial. The objective of this meta-analysis was to study the influence of GSTM1 polymorphisms on the occurrence of cervical cancer and to explore interactions between genes and human papillomavirus (HPV) infection and exposure to tobacco smoke. A meta-analysis was conducted on studies published up to June 12, 2025, from six databases: ScienceDirect, Embase, Scopus, PubMed, Google Scholar, Web of Science. Eligible studies included all case-control investigations that assessed the association between GSTM1 polymorphisms and the risk of cervical cancer. Odds ratios and confidence intervals from the studies were used to estimate the combined effect size. Statistical analyses were conducted using both the DerSimonian and Laird random-effects model and Mantel and Haenszel fixed-effect model with a 95% confidence interval. Subgroup analyses were performed to identify potential sources of variability. A significant association was observed between the GSTM1-null and an increased risk of Cervical Cancer (ORCC=1.47, Pz=0.011) and Squamous Intraepithelial Lesions (ORSIL=1.42, Pz=0.035) compared with the GSTM1-present. The included studies showed high heterogeneity. Overall, carriers of the GSTM1-null had a higher likelihood of developing Cervical Cancer compared to carriers of the GSTM1-present. In subgroup analyses, an increased risk associated with the GSTM1-null was found among Asian populations (ORCC=1.54, Pz=0.002) and according to sample type, in blood DNA extracts (ORCC=1.27, Pz=0.052). Furthermore, the GSTM1-null was associated with increased risk in HPV+ women (ORCC=4.88, Pz=0.005) and in women exposed to tobacco smoke (ORCC=1.35, Pz=0.033). According to histological type, GSTM1-null was also associated with the development of Squamous Cell Carcinoma (ORSCC=1.52, Pz=0.020). in conclusion, GSTM1-nullwere associated with an increased risk of cervical cancer in women, especially in HPV+ women and those exposed to tobacco smoke.
- Open Access
- 12 November 2025
- Published by Science Publishing Group in American Journal of BioScience
- Vol. 13 (6) , 210-217
Resistance to Beta-lactams by Klebsiella Co-Producing Resistance Enzymes at the Pietro Annigoni Research Centre (CERBA)
The misuse of antibiotics promotes the development of multi-resistance in bacteria both biochemically and genetically, as well as its ability to transmit to other bacteria. These microorganisms are capable of simultaneously producing resistance enzymes through resistance mechanisms that allow them to resist various classes of antibiotics at the same time and thus become multi-resistant. Our objective was to study resistance to beta-lactams by Klebsiella co-producing resistance enzymes isolated at the Pietro Annigoni Research Center (CERBA). The isolation and purification of bacterial strains isolated from stools, vaginal swabs and urine of internal and external patients of CERBA, were carried out on selective media and Muller Hinton (MH). The antibiogram was carried out according to the disk diffusion method. The API 20E biochemical gallery (Bio Mérieux, France) was used for the identification of enterobacteria and the bla NDM , bla SHV and bla TOHO genes were detected by conventional Polymerase Chain Reaction (PCR). A total of one hundred and twenty-two (122) strains of Gram-negative bacilli were collected and identified. Among them we have 23.77% (29/122) strains of Klebsiella including 86.21% isolated from urine, 6.90% isolated from stool and 6.90% isolated from vaginal swab. The antibiogram showed that all 29 Klebsiella strains were resistant to at least one of the beta-lactams studied, including 93.10% resistance to amoxicillin plus clavulanic acid, 37.93% resistance to ceftazidime, 27.59% resistance to ceftriaxone, 44.83% to cefotaxime, 20.70% to imipenem and 24.14% to aztreonam. Among the 29 Klebsiella strains 24.13% were non-carriers of resistance genes and 76.86% of the strains were carriers of at least one of the resistance genes. However, 62.06% of Klebsiella strains harbor the bla SHV gene, 41.38% of strains harbored bla NDM versus 10.34% of strains carrying the bla TOHO gene. Among the Klebsiella strains, 37.93% of the strains had coexistences of the genes, bla SHV + bla NDM , bla SHV + bla TOHO and bla TOHO + bla NDM respectively. However, the bla SHV gene was most common in Klebsiella ( Klebsiella sp and Klebsiella pneumoniae), followed by the bla NDM gene and the bla TOHO gene. This study has highlighted the multi-resistance of Klebsiella strains co-producing ESBLs of the bla NDM , bla SHV and bla TOHO type. The co-production of genes by certain strains, particularly Klebsiella strains, requires the development of new strategies in scientific research in order to find effective therapeutic solutions to destroy multi-resistant bacteria.
- 12 November 2025
- Published by Science Publishing Group in American Journal of BioScience
- Vol. 13 (6) , 210-217
Open AccessResistance to Beta-lactams by Klebsiella Co-Producing Resistance Enzymes at the Pietro Annigoni Research Centre (CERBA)
The misuse of antibiotics promotes the development of multi-resistance in bacteria both biochemically and genetically, as well as its ability to transmit to other bacteria. These microorganisms are capable of simultaneously producing resistance enzymes through resistance mechanisms that allow them to resist various classes of antibiotics at the same time and thus become multi-resistant. Our objective was to study resistance to beta-lactams by Klebsiella co-producing resistance enzymes isolated at the Pietro Annigoni Research Center (CERBA). The isolation and purification of bacterial strains isolated from stools, vaginal swabs and urine of internal and external patients of CERBA, were carried out on selective media and Muller Hinton (MH). The antibiogram was carried out according to the disk diffusion method. The API 20E biochemical gallery (Bio Mérieux, France) was used for the identification of enterobacteria and the bla NDM , bla SHV and bla TOHO genes were detected by conventional Polymerase Chain Reaction (PCR). A total of one hundred and twenty-two (122) strains of Gram-negative bacilli were collected and identified. Among them we have 23.77% (29/122) strains of Klebsiella including 86.21% isolated from urine, 6.90% isolated from stool and 6.90% isolated from vaginal swab. The antibiogram showed that all 29 Klebsiella strains were resistant to at least one of the beta-lactams studied, including 93.10% resistance to amoxicillin plus clavulanic acid, 37.93% resistance to ceftazidime, 27.59% resistance to ceftriaxone, 44.83% to cefotaxime, 20.70% to imipenem and 24.14% to aztreonam. Among the 29 Klebsiella strains 24.13% were non-carriers of resistance genes and 76.86% of the strains were carriers of at least one of the resistance genes. However, 62.06% of Klebsiella strains harbor the bla SHV gene, 41.38% of strains harbored bla NDM versus 10.34% of strains carrying the bla TOHO gene. Among the Klebsiella strains, 37.93% of the strains had coexistences of the genes, bla SHV + bla NDM , bla SHV + bla TOHO and bla TOHO + bla NDM respectively. However, the bla SHV gene was most common in Klebsiella ( Klebsiella sp and Klebsiella pneumoniae), followed by the bla NDM gene and the bla TOHO gene. This study has highlighted the multi-resistance of Klebsiella strains co-producing ESBLs of the bla NDM , bla SHV and bla TOHO type. The co-production of genes by certain strains, particularly Klebsiella strains, requires the development of new strategies in scientific research in order to find effective therapeutic solutions to destroy multi-resistant bacteria.
- Open Access
- 10 July 2025
- Published by Science Publishing Group in Biochemistry and Molecular Biology
- Vol. 10 (3) , 52-60
Multidrug Resistance of Escherichia Coli by Production of TOHO, NDM and SHV Type Enzymes at the Pietro Annigoni Research Centre (CERBA)
Antibiotics are drugs used to fight infections caused by bacteria. They are one of the most important discoveries in medicine that has saved and continues to save millions of lives each year, but their effectiveness is threatened because bacteria can adapt and resist treatment. The present study aimed to identify the bla NDM, bla SHV and bla TOHO genes in Escherichia coli strains isolated from patients at the Pietro Annigoni Biomolecular Research Center (CERBA) in Ouagadougou. The isolation and purification of bacterial strains from the stools and urine of internal and external patients of CERBA were carried out on selective media and Muller Hinton (MH) medium. The antibiogram was carried out according to the disc diffusion method. The API 20E biochemical gallery (Bio Mérieux, France) was used for the identification of enterobacteria and the bla NDM, bla SHV and bla TOHO genes were detected by conventional Polymerase Chain Reaction (PCR). A total of one hundred and twenty-two (122) strains of Gram-negative bacilli were isolated, including 85 (69.67%) strains of E. coli. All E. coli strains were resistant to at least one of the antibiotics studied. Conventional PCR showed that 48.23% (41/85) of E. coli strains carried at least one gene studied. Among the 85 E. coli strains, 35.30% (30/85) of the strains harbored the bla NDM gene, 18.82% (16/85) bla SHV and 8.23% (7/85) of strains carrying the bla TOHO gene. Among the 85 strains, the coexistence of bla SHV genes + blah NDM, blah SHV + blah TOHO, blah TOHO + bla NDM, and bla SHV + bla NDM + bla TOHO were found in 16.47% (14/85) in total. This study has highlighted the multi-resistance of ESBL-producing E. coli strains carrying the bla NDM, bla SHV and bla TOHO genes. The strong coexistence of genes in certain E. coli strains requires efforts to find new therapeutic solutions to combat bacterial resistance.
- 10 July 2025
- Published by Science Publishing Group in Biochemistry and Molecular Biology
- Vol. 10 (3) , 52-60
Open AccessMultidrug Resistance of Escherichia Coli by Production of TOHO, NDM and SHV Type Enzymes at the Pietro Annigoni Research Centre (CERBA)
Antibiotics are drugs used to fight infections caused by bacteria. They are one of the most important discoveries in medicine that has saved and continues to save millions of lives each year, but their effectiveness is threatened because bacteria can adapt and resist treatment. The present study aimed to identify the bla NDM, bla SHV and bla TOHO genes in Escherichia coli strains isolated from patients at the Pietro Annigoni Biomolecular Research Center (CERBA) in Ouagadougou. The isolation and purification of bacterial strains from the stools and urine of internal and external patients of CERBA were carried out on selective media and Muller Hinton (MH) medium. The antibiogram was carried out according to the disc diffusion method. The API 20E biochemical gallery (Bio Mérieux, France) was used for the identification of enterobacteria and the bla NDM, bla SHV and bla TOHO genes were detected by conventional Polymerase Chain Reaction (PCR). A total of one hundred and twenty-two (122) strains of Gram-negative bacilli were isolated, including 85 (69.67%) strains of E. coli. All E. coli strains were resistant to at least one of the antibiotics studied. Conventional PCR showed that 48.23% (41/85) of E. coli strains carried at least one gene studied. Among the 85 E. coli strains, 35.30% (30/85) of the strains harbored the bla NDM gene, 18.82% (16/85) bla SHV and 8.23% (7/85) of strains carrying the bla TOHO gene. Among the 85 strains, the coexistence of bla SHV genes + blah NDM, blah SHV + blah TOHO, blah TOHO + bla NDM, and bla SHV + bla NDM + bla TOHO were found in 16.47% (14/85) in total. This study has highlighted the multi-resistance of ESBL-producing E. coli strains carrying the bla NDM, bla SHV and bla TOHO genes. The strong coexistence of genes in certain E. coli strains requires efforts to find new therapeutic solutions to combat bacterial resistance.
- 10 June 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-9
Precore G1896A mutation of hepatitis B virus in patients with chronic hepatitis B, hepatic cirrhosis, and hepatocellular carcinoma in Burkina Faso
Background Hepatitis B virus (HBV) infection, which can progress to liver cancer and even death, remains a public health problem. The high variability of HBV leading to the accumulation of mutations influences the natural history of this infection. Mutations in the precore/core region, in particular the G1896A mutation, have been associated with severe forms of liver disease in certain populations around the world. The aim of this study was to determine the molecular epidemiology of the HBV precore G1896A mutation and its relationship to hepatic complications in HBV chronically infected patients. Methods Classical nested PCR was used to amplify the HBV precore region. A total of 97 samples consisting of 53 cases of chronic hepatitis B (CHB), 18 cases of hepatic cirrhosis (HC) and 26 cases of hepatocellular carcinoma (HCC) were amplified. The G1896A mutation was determined by enzymatic digestion on 81 samples using the restriction enzyme Bsu36I. Serological (HBeAg, anti-HBe Ac), biochemical (ALT) and virological (HBV-DNA viral load) tests were performed. Results The frequency of the G1896A mutation was 44.44% in our study population. It was 56.82% in CHB cases, 28.57% in HC cases and 30.43% in HCC. The G1896A mutation was found more in subjects with a negative HBeAg status than in those with a positive HBeAg (p = 0.05) in the CHB subgroup. The DNA level was higher in subjects carrying wild-type strains for the G1896A mutation (p > 0.05). ALT levels were lower in subjects carrying the G1896A mutation than in those infected with wild-type strains (p = 0.006) in the HBC subgroup. Conclusion This study, conducted on patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC), showed that the frequency of the precore G1896A mutation was 44.44%. We found no correlation between this mutation and cirrhosis and HCC. However, it was more found in subjects with chronic hepatitis B and was associated with HBeAg negativity in the latter. It would therefore be involved in the elimination of this protein partly responsible for the persistence of HBV infection and could be a molecular marker for clinicians in the management of patients infected with HBV with negative HBeAg and positive anti-HBe antibodies. However, studies on other mutations of the precore gene would be necessary to obtain more conclusive results in terms of effective treatment.
- 10 June 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-9
Precore G1896A mutation of hepatitis B virus in patients with chronic hepatitis B, hepatic cirrhosis, and hepatocellular carcinoma in Burkina Faso
Background Hepatitis B virus (HBV) infection, which can progress to liver cancer and even death, remains a public health problem. The high variability of HBV leading to the accumulation of mutations influences the natural history of this infection. Mutations in the precore/core region, in particular the G1896A mutation, have been associated with severe forms of liver disease in certain populations around the world. The aim of this study was to determine the molecular epidemiology of the HBV precore G1896A mutation and its relationship to hepatic complications in HBV chronically infected patients. Methods Classical nested PCR was used to amplify the HBV precore region. A total of 97 samples consisting of 53 cases of chronic hepatitis B (CHB), 18 cases of hepatic cirrhosis (HC) and 26 cases of hepatocellular carcinoma (HCC) were amplified. The G1896A mutation was determined by enzymatic digestion on 81 samples using the restriction enzyme Bsu36I. Serological (HBeAg, anti-HBe Ac), biochemical (ALT) and virological (HBV-DNA viral load) tests were performed. Results The frequency of the G1896A mutation was 44.44% in our study population. It was 56.82% in CHB cases, 28.57% in HC cases and 30.43% in HCC. The G1896A mutation was found more in subjects with a negative HBeAg status than in those with a positive HBeAg (p = 0.05) in the CHB subgroup. The DNA level was higher in subjects carrying wild-type strains for the G1896A mutation (p > 0.05). ALT levels were lower in subjects carrying the G1896A mutation than in those infected with wild-type strains (p = 0.006) in the HBC subgroup. Conclusion This study, conducted on patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC), showed that the frequency of the precore G1896A mutation was 44.44%. We found no correlation between this mutation and cirrhosis and HCC. However, it was more found in subjects with chronic hepatitis B and was associated with HBeAg negativity in the latter. It would therefore be involved in the elimination of this protein partly responsible for the persistence of HBV infection and could be a molecular marker for clinicians in the management of patients infected with HBV with negative HBeAg and positive anti-HBe antibodies. However, studies on other mutations of the precore gene would be necessary to obtain more conclusive results in terms of effective treatment.
- 10 January 2024
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 13 (1) , 164-172
Trends in HIV Prevalence Among Pregnant Women and Children Under 18 Months of Age from 2019 to 2022 at Hospital Saint Camille in Ouagadougou, Burkina Faso
Vertical transmission of the human immunodeficiency virus (HIV) remains a major concern in sub-Saharan African countries such as Burkina Faso, despite the implementation of various prevention and elimination programs. This study aimed to determine the prevalence of HIV infection in pregnant women and children under 18 months of age in the context of the elimination of mother-to-child transmission of HIV in Burkina Faso. Methods: This was a retrospective study with a collection period from 2019 to 2022. Data were collected at Hôpital Saint Camille de Ouagadougou and the study population was pregnant women received at antenatal consultations (ANC) and children 18 months of age borned to HIV-positive mothers. The most represented age group was over 25. The overall prevalence of HIV among all pregnant women seen at antenatal clinics who tested positive fell from 3.0 % in 2019 to 1.50% in 2022. HIV prevalence among those seen at antenatal clinics who did not know their HIV status beforehand also fell, from 1.22% in 2019 to 0.42% in 2022, a reduction of 2.90%. HIV prevalence in children under 18 months of age by PCR changed from 5.56% (06/108) in 2017 to 0.0% (0/57) in 2022. The number of partners of pregnant women who received an HIV test fell from 51 partners in 2019 to 16 partners in 2022. Conclusion: This study shows a significant reduction in the prevalence of HIV infection among pregnant women and children. Elimination programs must reinforce efforts for a considerable reduction in MTCT/HIV. Vertical transmission of the human immunodeficiency virus (HIV) remains a major concern in sub-Saharan African countries such as Burkina Faso, despite the implementation of various prevention and elimination programs. This study aimed to determine the prevalence of HIV infection in pregnant women and children under 18 months of age in the context of the elimination of mother-to-child transmission of HIV in Burkina Faso. Methods: This was a retrospective study with a collection period from 2019 to 2022. Data were collected at Hôpital Saint Camille de Ouagadougou and the study population was pregnant women received at antenatal consultations (ANC) and children 18 months of age borned to HIV-positive mothers. The most represented age group was over 25. The overall prevalence of HIV among all pregnant women seen at antenatal clinics who tested positive fell from 3.0 % in 2019 to 1.50% in 2022. HIV prevalence among those seen at antenatal clinics who did not know their HIV status beforehand also fell, from 1.22% in 2019 to 0.42% in 2022, a reduction of 2.90%. HIV prevalence in children under 18 months of age by PCR changed from 5.56% (06/108) in 2017 to 0.0% (0/57) in 2022. The number of partners of pregnant women who received an HIV test fell from 51 partners in 2019 to 16 partners in 2022. Conclusion: This study shows a significant reduction in the prevalence of HIV infection among pregnant women and children. Elimination programs must reinforce efforts for a considerable reduction in MTCT/HIV.
- 10 January 2024
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 13 (1) , 164-172
Trends in HIV Prevalence Among Pregnant Women and Children Under 18 Months of Age from 2019 to 2022 at Hospital Saint Camille in Ouagadougou, Burkina Faso
Vertical transmission of the human immunodeficiency virus (HIV) remains a major concern in sub-Saharan African countries such as Burkina Faso, despite the implementation of various prevention and elimination programs. This study aimed to determine the prevalence of HIV infection in pregnant women and children under 18 months of age in the context of the elimination of mother-to-child transmission of HIV in Burkina Faso. Methods: This was a retrospective study with a collection period from 2019 to 2022. Data were collected at Hôpital Saint Camille de Ouagadougou and the study population was pregnant women received at antenatal consultations (ANC) and children 18 months of age borned to HIV-positive mothers. The most represented age group was over 25. The overall prevalence of HIV among all pregnant women seen at antenatal clinics who tested positive fell from 3.0 % in 2019 to 1.50% in 2022. HIV prevalence among those seen at antenatal clinics who did not know their HIV status beforehand also fell, from 1.22% in 2019 to 0.42% in 2022, a reduction of 2.90%. HIV prevalence in children under 18 months of age by PCR changed from 5.56% (06/108) in 2017 to 0.0% (0/57) in 2022. The number of partners of pregnant women who received an HIV test fell from 51 partners in 2019 to 16 partners in 2022. Conclusion: This study shows a significant reduction in the prevalence of HIV infection among pregnant women and children. Elimination programs must reinforce efforts for a considerable reduction in MTCT/HIV. Vertical transmission of the human immunodeficiency virus (HIV) remains a major concern in sub-Saharan African countries such as Burkina Faso, despite the implementation of various prevention and elimination programs. This study aimed to determine the prevalence of HIV infection in pregnant women and children under 18 months of age in the context of the elimination of mother-to-child transmission of HIV in Burkina Faso. Methods: This was a retrospective study with a collection period from 2019 to 2022. Data were collected at Hôpital Saint Camille de Ouagadougou and the study population was pregnant women received at antenatal consultations (ANC) and children 18 months of age borned to HIV-positive mothers. The most represented age group was over 25. The overall prevalence of HIV among all pregnant women seen at antenatal clinics who tested positive fell from 3.0 % in 2019 to 1.50% in 2022. HIV prevalence among those seen at antenatal clinics who did not know their HIV status beforehand also fell, from 1.22% in 2019 to 0.42% in 2022, a reduction of 2.90%. HIV prevalence in children under 18 months of age by PCR changed from 5.56% (06/108) in 2017 to 0.0% (0/57) in 2022. The number of partners of pregnant women who received an HIV test fell from 51 partners in 2019 to 16 partners in 2022. Conclusion: This study shows a significant reduction in the prevalence of HIV infection among pregnant women and children. Elimination programs must reinforce efforts for a considerable reduction in MTCT/HIV.
- 9 October 2023
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (11) , 9239-9247
Prevalence and patterns of chromosomal abnormalities in patients suspected of genetic disorders: insights from a study in Ouagadougou, Burkina Faso
Background Chromosomal abnormalities contribute significantly to human morbidity and mortality, leading to various pathologies. This study aimed to assess the prevalence of chromosomal abnormalities among patients suspected of genetic disorders in Ouagadougou, Burkina Faso. Methods and results A descriptive cross-sectional study was conducted from January 1, 2018, to July 16, 2021, involving patients from different university hospitals in Ouagadougou. Blood samples were collected at Hôpital Saint Camille de Ouagadougou (HOSCO) and sent to the Cerba laboratory in France for cytogenetic analysis. A total of 61 cases with suspected genetic disorders were referred for cytogenetic examination. The average age of the patients was 26.81 years ± 18.92, ranging from 1 month to 68 years. Among the cases, 37 (60.65%) exhibited chromosomal abnormalities. Structural abnormalities were the most prevalent (78.38%), while number anomalies accounted for 21.62% of the cases. Chronic myeloid leukemia was detected in 59.45% of cases, followed by free and homogeneous trisomy 21 (18.91%) and sexual inversion (8.10%). Additionally, one case each of Turner syndrome and Klinefelter syndrome were identified. Conclusion This this study revealed a high frequency of chromosomal abnormalities, with a predominance of structural abnormalities, among patients suspected of genetic disorders in Ouagadougou. The findings emphasize the significance of genetic evaluation and counseling services in the region, particularly for autosomal abnormalities.
- 9 October 2023
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (11) , 9239-9247
Prevalence and patterns of chromosomal abnormalities in patients suspected of genetic disorders: insights from a study in Ouagadougou, Burkina Faso
Background Chromosomal abnormalities contribute significantly to human morbidity and mortality, leading to various pathologies. This study aimed to assess the prevalence of chromosomal abnormalities among patients suspected of genetic disorders in Ouagadougou, Burkina Faso. Methods and results A descriptive cross-sectional study was conducted from January 1, 2018, to July 16, 2021, involving patients from different university hospitals in Ouagadougou. Blood samples were collected at Hôpital Saint Camille de Ouagadougou (HOSCO) and sent to the Cerba laboratory in France for cytogenetic analysis. A total of 61 cases with suspected genetic disorders were referred for cytogenetic examination. The average age of the patients was 26.81 years ± 18.92, ranging from 1 month to 68 years. Among the cases, 37 (60.65%) exhibited chromosomal abnormalities. Structural abnormalities were the most prevalent (78.38%), while number anomalies accounted for 21.62% of the cases. Chronic myeloid leukemia was detected in 59.45% of cases, followed by free and homogeneous trisomy 21 (18.91%) and sexual inversion (8.10%). Additionally, one case each of Turner syndrome and Klinefelter syndrome were identified. Conclusion This this study revealed a high frequency of chromosomal abnormalities, with a predominance of structural abnormalities, among patients suspected of genetic disorders in Ouagadougou. The findings emphasize the significance of genetic evaluation and counseling services in the region, particularly for autosomal abnormalities.
- Open Access
- 17 December 2022
- Published by Wiley in Prostate Cancer
- Vol. 2022, 1-9
Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso
Background. Genetic factors are one of the significant contributors to prostate cancer (PCa) development, and hereditary prostate cancer 2 (HPC2) locus gene ELAC2 is considered a PCa susceptibility region. The HPC2/ELAC2 gene has been identified by linkage analysis in familial prostate cancer patients in the United States but has never been studied in Burkina Faso. The objective of the present study was to analyze the carriage of the C650T (Ser217Leu) and G1621A (Ala541Thr) mutations of the ELAC2 gene and the risk factors in prostate cancer patients in Burkina Faso. Methods. This case-control study included 76 participants, including 38 histologically confirmed prostate cancer cases and 38 healthy controls without prostate abnormalities. PCR combined with restriction fragment length polymorphism (RFLP) was used to characterize the genotypes of the Ser217Leu and Ala541Thr polymorphisms of the ELAC2 gene. The correlations between the different genotypes and risk factors for prostate cancer were investigated. Results. The C650T mutation was present in 44.73% of prostate cancer cases and 47.37% of controls. The G1621A mutation was present in 26.32% of prostate cancer cases and 15.79% of controls. We did not detect an association between prostate cancer risk and the Ser217Leu ( ) and Ala541Thr ( ) variants of the ELAC2 gene. Also, the two ELAC2 SNPs did not correlate with clinical stage, prostate-specific antigen (PSA) level at diagnosis, or the Gleason score on biopsies. However, we found that 100% of homozygous carriers of the T650 mutation have an A1621 mutation ( ). Conclusion. Ser217Leu and Ala541Thr polymorphisms of ELAC2, considered alone or in combination, are not associated with prostate cancer risk.
- 17 December 2022
- Published by Wiley in Prostate Cancer
- Vol. 2022, 1-9
Open AccessCarriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso
Background. Genetic factors are one of the significant contributors to prostate cancer (PCa) development, and hereditary prostate cancer 2 (HPC2) locus gene ELAC2 is considered a PCa susceptibility region. The HPC2/ELAC2 gene has been identified by linkage analysis in familial prostate cancer patients in the United States but has never been studied in Burkina Faso. The objective of the present study was to analyze the carriage of the C650T (Ser217Leu) and G1621A (Ala541Thr) mutations of the ELAC2 gene and the risk factors in prostate cancer patients in Burkina Faso. Methods. This case-control study included 76 participants, including 38 histologically confirmed prostate cancer cases and 38 healthy controls without prostate abnormalities. PCR combined with restriction fragment length polymorphism (RFLP) was used to characterize the genotypes of the Ser217Leu and Ala541Thr polymorphisms of the ELAC2 gene. The correlations between the different genotypes and risk factors for prostate cancer were investigated. Results. The C650T mutation was present in 44.73% of prostate cancer cases and 47.37% of controls. The G1621A mutation was present in 26.32% of prostate cancer cases and 15.79% of controls. We did not detect an association between prostate cancer risk and the Ser217Leu ( ) and Ala541Thr ( ) variants of the ELAC2 gene. Also, the two ELAC2 SNPs did not correlate with clinical stage, prostate-specific antigen (PSA) level at diagnosis, or the Gleason score on biopsies. However, we found that 100% of homozygous carriers of the T650 mutation have an A1621 mutation ( ). Conclusion. Ser217Leu and Ala541Thr polymorphisms of ELAC2, considered alone or in combination, are not associated with prostate cancer risk.
- Open Access
- 8 August 2022
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 22 (1) , 1-9
First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso
Background: Vulvovaginal candidiasis is an important cause of morbidity among women due to Candida species. In the last decades, resistance to azoles, first-line antifungals has increased. One molecular mechanism of azole resistance by Candida involves mutations in the ERG11 gene encoding lanosterol 14-α-demethylase, the target enzyme. This study was conducted to identify the clinical Candida species associated in vulvovaginal candidiasis; to determine the rate of antifungal resistance among Candida albicans isolates and to determine mutated ERG11 gene at Saint Camille Hospital in Ouagadougou, Burkina Faso. Methods: Antifungals susceptibility were performed using Kirby–Bauer disk diffusion method. ERG11 gene was detected using conventional PCR in C. albicans isolates resistant to at least one azole. Results: Out of 262 clinical strains isolated, C. albicans accounted for 59.90%, followed by Candida glabrata 27.86%, Candida famata 7.25%, Candida tropicalis 3.05% and Saccharomyces cerevisiae 1.91%. Resistance rate of fluconazole to C. albicans was 59.54%. ERG11 gene was found in 9.79% of 92 C. albicans strains resistant to azoles. Conclusions: This detection of mutated ERG11 gene in C. albicans is the first in Burkina Faso and may be a cause of azole resistance in recurrent Candida vulvovaginitis.
- 8 August 2022
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 22 (1) , 1-9
Open AccessFirst detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso
Background: Vulvovaginal candidiasis is an important cause of morbidity among women due to Candida species. In the last decades, resistance to azoles, first-line antifungals has increased. One molecular mechanism of azole resistance by Candida involves mutations in the ERG11 gene encoding lanosterol 14-α-demethylase, the target enzyme. This study was conducted to identify the clinical Candida species associated in vulvovaginal candidiasis; to determine the rate of antifungal resistance among Candida albicans isolates and to determine mutated ERG11 gene at Saint Camille Hospital in Ouagadougou, Burkina Faso. Methods: Antifungals susceptibility were performed using Kirby–Bauer disk diffusion method. ERG11 gene was detected using conventional PCR in C. albicans isolates resistant to at least one azole. Results: Out of 262 clinical strains isolated, C. albicans accounted for 59.90%, followed by Candida glabrata 27.86%, Candida famata 7.25%, Candida tropicalis 3.05% and Saccharomyces cerevisiae 1.91%. Resistance rate of fluconazole to C. albicans was 59.54%. ERG11 gene was found in 9.79% of 92 C. albicans strains resistant to azoles. Conclusions: This detection of mutated ERG11 gene in C. albicans is the first in Burkina Faso and may be a cause of azole resistance in recurrent Candida vulvovaginitis.
- Open Access
- 14 December 2021
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 21 (4) , 1715-21
Molecular characterization of high-risk humanpapillomavirus genotypes in women with or without cervical lesions at VIA/VILI in Kara, Togo
Background: Persistent infection with high-risk (HR) papillomavirus (HPV) genotypes plays a central role in the pathogenesis of invasive cervical cancer. Objectives: This study aimed to determine the prevalence and distribution of HR-HPV among women with or without cervical lesions at VIA/VILI in Togo. Methods: Cervical samples were collected from 238 women with or without cervical lesions at VIA / VILI and[c3] DNA [c4]was extracted and analyzed by real-time multiplex PCR. Logistic regression analysis was used to determined risk factors associated with HPV infection. inPietro Annigoni Biomolecular Research Center (CERBA / LABIOGENE) in Burkina Faso. Results: The age of the women ranged from 17 to 61 years old, and most were married (73.5%). The prevalence of HRHPV was 35.71% and this was higher in the age range 35-39 years. The six most common genotypes were HPV 31 (18.7%), HPV 52 (13.82%), HPV 68 (13.01%), HPV 66 (9.76%), HPV 58 (8.13%) and HPV 56 (8.13%). Genotypes HPV 18 (4.07%) and HPV 16 (0.81%) were less frequent.[c5] Married or living with a partner was associated with HPV infection ( OR=2,17, IC [1.20-3.91], pConclusion: This study allowed characterizing for the first time in Togo, HR-HPV genotypes. This will help mappingHR-HPV genotypes circulating in West Africa. Keywords: Human papillomavirus; High-risk; Genotyping; Kara; Togo.
- 14 December 2021
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 21 (4) , 1715-21
Open AccessMolecular characterization of high-risk humanpapillomavirus genotypes in women with or without cervical lesions at VIA/VILI in Kara, Togo
Background: Persistent infection with high-risk (HR) papillomavirus (HPV) genotypes plays a central role in the pathogenesis of invasive cervical cancer. Objectives: This study aimed to determine the prevalence and distribution of HR-HPV among women with or without cervical lesions at VIA/VILI in Togo. Methods: Cervical samples were collected from 238 women with or without cervical lesions at VIA / VILI and[c3] DNA [c4]was extracted and analyzed by real-time multiplex PCR. Logistic regression analysis was used to determined risk factors associated with HPV infection. inPietro Annigoni Biomolecular Research Center (CERBA / LABIOGENE) in Burkina Faso. Results: The age of the women ranged from 17 to 61 years old, and most were married (73.5%). The prevalence of HRHPV was 35.71% and this was higher in the age range 35-39 years. The six most common genotypes were HPV 31 (18.7%), HPV 52 (13.82%), HPV 68 (13.01%), HPV 66 (9.76%), HPV 58 (8.13%) and HPV 56 (8.13%). Genotypes HPV 18 (4.07%) and HPV 16 (0.81%) were less frequent.[c5] Married or living with a partner was associated with HPV infection ( OR=2,17, IC [1.20-3.91], pConclusion: This study allowed characterizing for the first time in Togo, HR-HPV genotypes. This will help mappingHR-HPV genotypes circulating in West Africa. Keywords: Human papillomavirus; High-risk; Genotyping; Kara; Togo.